Search Results - "Rogai, Francesca"

Refine Results
  1. 1

    A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies by Beeg, Marten, Nobili, Alessandro, Orsini, Barbara, Rogai, Francesca, Gilardi, Daniela, Fiorino, Gionata, Danese, Silvio, Salmona, Mario, Garattini, Silvio, Gobbi, Marco

    Published in Scientific reports (14-02-2019)
    “…Therapeutic drug and immunogenicity monitoring (TDIM) is increasingly proposed to guide therapy with biologics, characterised by high inter-individual…”
    Get full text
    Journal Article
  2. 2
  3. 3

    PPARγ in Inflammatory Bowel Disease by Annese, Vito, Rogai, Francesca, Settesoldi, Alessia, Bagnoli, Siro

    Published in PPAR Research (01-01-2012)
    “…Peroxisome proliferator-activated receptor gamma (PPARγ) is member of a family of nuclear receptors that interacts with nuclear proteins acting as coactivators…”
    Get full text
    Journal Article
  4. 4

    Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors by Papi, Claudio, Fascì-Spurio, Federica, Rogai, Francesca, Settesoldi, Alessia, Margagnoni, Giovanna, Annese, Vito

    Published in Digestive and liver disease (01-12-2013)
    “…Abstract In recent years mucosal healing has emerged as an important therapeutic goal for patients with inflammatory bowel disease. Growing evidence suggests…”
    Get full text
    Journal Article
  5. 5

    Golimumab in inflammatory bowel diseases: present and future scenarios by Dragoni, Gabriele, Le Grazie, Marco, Orlandini, Beatrice, Rogai, Francesca

    Published in Clinical journal of gastroenterology (01-02-2019)
    “…Golimumab is the third anti-TNF agent approved for the treatment of ulcerative colitis. Despite initial success demonstrated by PURSUIT trials, only few…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real‐life experience from two Italian IBD centers by Orlandini, Beatrice, Dragoni, Gabriele, Variola, Angela, Massella, Arianna, Bagnoli, Siro, Campi, Riccardo, Rogai, Francesca

    Published in Journal of digestive diseases (01-08-2018)
    “…OBJECTIVE To evaluate the efficacy and safety of golimumab in biological naive and experienced patients with moderately to severely active ulcerative colitis…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany by Manetti, Natalia, Bagnoli, Siro, Rogai, Francesca, Bonanomi, Andrea G, Vannozzi, Giancarlo, Giannotta, Martina, Annese, Vito

    Published in Inflammatory bowel diseases (01-08-2016)
    “…The disease course and colectomy rate of ulcerative colitis (UC) vary largely in population-based and referral center cohorts. We retrospectively evaluated our…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey by Innocenti, Tommaso, Roselli, Jenny, Taylor, Alice, Dragoni, Gabriele, Lynch, Erica Nicola, Campani, Claudia, Gottin, Matteo, Bagnoli, Siro, Macrì, Giuseppe, Rogai, Francesca, Milani, Stefano, Galli, Andrea, Milla, Monica

    Published in Journal of digestive diseases (01-08-2022)
    “…Objectives Inflammatory bowel disease (IBD) can affect young and reproductively active patients. Our aim was to analyze pregnancy outcomes in a large cohort of…”
    Get full text
    Journal Article